Edesa Biotech, Inc. — Income Charts
34 quarters of history · ending 2021-09-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-100.0% -$500
$0
Cost of Revenue↓-100.0% -$2K
$0
R&D↑+257.5% +$3M
$4M
D&A↓-0.3% -$85
$29K
Operating Income↓-243.4% -$4M
$-6M
EBITDA↓-0.3% -$85
$29K
Interest Income↓-96.0% -$18K
$747
Other Income/Expense↑+116506.8% +$1M
$1M
Pretax Income↓-169.5% -$3M
$-5M
Tax Provision
$0
Net Income
$23M
Operating Margin↑+262462.9pts
-1607.9%
Net Margin↑+257195.9pts
-1605.5%
Effective Tax Rate↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
26.5%
Operating Lease CostNEW↑+12.9% +$2.38B
$20.89B
Revenue YoY Variation↓-0.1pts
-100.0%
Income YoY Variation↓-209.5pts
-243.4%
Revenue QoQ Variation↓-26.3pts
-100.0%
Income QoQ Variation↑+52.8pts
36.1%